Radiologist lose piece of the radioisotope pie
Endocrinologists are biting into radiology’s control over the management of nuclear imaging procedures involving an administration of radioiodine.
Endocrinologists are biting into radiology’s control over the management of nuclear imaging procedures involving an administration of radioiodine.
An analysis of Medicare patient procedural data by Dr. Charles .M. Intenzo, a nuclear physician at Thomas Jefferson University in Philadelphia found that radiology’s share of procedures involving the administration of radioiodine dropped 7% from 1996 to 2007. At the same time, the number of procedures administered by endocrinologists jumped by nearly one-third (32%).
The total number of such procedures covered by Medicare Part B remained stable over the 10-year period. Medicare covered 13,273 procedures requiring radioiodine in 1996. The total in 2007 was 13,004.
Endocrinology practice revolves around a limited number of applications, so practitioners are naturally attracted to these procedures as a new source of income. Regulatory barriers to their involvement have fallen as the Department of Energy has watered down the minimum training requirements for isotope handling and administration, Intenzo said.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.
